---
$id: https://graph.org.ai/products/commodity/51281902
$type: Product
source: UNSPSC
code: "51281902"
title: "Rifabutin"
class: "51281900"
classTitle: "Antineoplastics"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Rifabutin

**UNSPSC Code**: 51281902
**Class**: [Antineoplastics](Antineoplastics.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a heat shock protein inhibitor and antineoplastic antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1W306TDA6S. European Medicines Agency schedules Rifabutin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10304MIG. Rifabutin generally arises in the molecular formula C46H62N4O11. The term RIFABUTIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 39, no. 5, 1985, list 25.) RIFABUTIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule rifabutin under HS 29419000 and SITC 54139. As of Q4 2014, RIFABUTIN remains the US FDA Preferred Term for this commodity. Rifabutin bears US NLM identifiers UMLS ID C0140575 and NCI Concept Code C1408. SMILES: O(C1C(C(O)C(C(O)C(C)C=CC=C(C(=O)NC2=C3NC4(N=C3C3C(C2=O)C(O)C(C2OC(OC=CC(OC)C1C)(C(=O)C32)C)C)CCN(CC4)CC(C)C)C)C)C)C(=O)C.

